Sunday, January 04, 2015 3:41:04 PM
That was the message during the Q3 conference call. Since government business in Q3 was so low, and Q4 includes end of the fiscal year for the government, absolutely any business coming from the government will have a positive impact and provide upside surprise.
Beyond that, I think 2015 should be the year we really see the turnaround begin to take effect. Revenues have begun to turn the corner with the new products and expanding client base (away from government). As things progress, government business is going to become irrelevant to the point that it won't be necessary at all - any government revenues will be considered icing on the cake.
It's still a long haul, however, the financials remain extremely strong, the company is cash flow positive, and losses that are posted are minimal. The plan that management has in place is a very good one and as long as they continue to execute on it, the future is very bright for the company.
We still have about 9 weeks until the earnings announcement. Assuming we're not going to get any news in the near-term, best we can hope for is a January Effect bounce to get shares back to the normal trading range between $3.50 and $3.75.
Recent ULBI News
- Ultralife Corporation Reports First Quarter Results • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Ultralife Corporation to Report First Quarter Results on April 25, 2024 • GlobeNewswire Inc. • 04/11/2024 08:01:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:30:29 PM
- Ultralife Corporation Reports Fourth Quarter Results • GlobeNewswire Inc. • 02/15/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 06:50:40 PM
- Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024 • GlobeNewswire Inc. • 01/29/2024 09:30:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 05:54:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:04:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2023 09:03:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2023 09:14:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:19:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 03:39:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/01/2023 08:44:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 11:32:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 11:30:10 AM
- Ultralife Corporation Reports Third Quarter Results • GlobeNewswire Inc. • 10/26/2023 11:00:00 AM
- Ultralife Corporation to Report Third Quarter Results on October 26, 2023 • GlobeNewswire Inc. • 10/12/2023 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 07:40:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 12:28:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2023 03:57:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/27/2023 11:31:47 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 11:30:29 AM
- Ultralife Corporation Reports Second Quarter Results • GlobeNewswire Inc. • 07/27/2023 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 07:51:09 PM
- Ultralife Corporation to Report Second Quarter Results on July 27, 2023 • GlobeNewswire Inc. • 07/13/2023 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM